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ABSTRACT
Objective: To identify patient and practitioner factors
that influence cancer diagnosis via emergency
presentation (EP).
Design: Systematic review.
Data sources: MEDLINE, EMBASE, CINAHL,
EBM Reviews, Science and Social Sciences Citation
Indexes, Conference Proceedings Citation Index-
Science and Conference Proceedings Citation Index-
Social Science and Humanities. Searches were
undertaken from 1996 to 2014. No language
restrictions were applied.
Study selection: Studies of any design assessing
factors associated with diagnosis of colorectal or lung
cancer via EP, or describing an intervention to impact
on EP, were included. Studies involving previously
diagnosed cancer patients, assessing only referral
pathway effectiveness, outcomes related to diagnosis
or post-EP management were excluded. The population
was individual or groups of adult patients or primary
care practitioners. Two authors independently screened
studies for inclusion.
Results: 22 studies with over 200 000 EPs were
included, most providing strong evidence. Five were
graded ‘insufficient’, primarily due to missing
information rather than methodological weakness.
Older patient age was associated with EP for lung and
colorectal cancers (OR 1.11–11.03 and 1.19–5.85,
respectively). Women were more at risk of EP for lung
but not colorectal cancer. Higher deprivation increased
the likelihood of lung cancer EP, but evidence for
colorectal was less conclusive. Being unmarried
(or divorced/widowed) increased the likelihood of
EP for colorectal cancer, which was also associated
with pain, obstruction and weight loss. Lack of a
regular source of primary care, and lower primary
care use were positively associated with EP. Only
three studies considered practitioner factors, two
involving diagnostic tests. No conclusive evidence was
found.
Conclusions: Patient-related factors, such as age,
gender and deprivation, increase the likelihood of
cancer being diagnosed as the result of an EP, while
cancer symptoms and patterns of healthcare utilisation
are also relevant. Further work is needed to understand
the context in which risk factors for EP exist and
influence help-seeking.
INTRODUCTION
Cancer remains one of the UK’s biggest
health issues, both in terms of morbidity and
mortality. In recent years, there has been
increasing interest in the pathway to diagno-
sis,1 as international data have shown that
1 year survival for many cancers is poorer in
the UK than in comparable countries.2 3 As
such, it is important to target groups where
some of the worst outcomes have been iden-
tiﬁed, as there is potentially most to gain
from understanding pathways to diagnosis
for such patients.
In the UK, the main routes to cancer diag-
nosis are considered to be screen detected,
Strengths and limitations of this study
▪ This review has for the first time synthesised
available evidence on factors associated with
diagnosis of colorectal or lung cancer during an
emergency presentation. As such, it is a valuable
addition to previous work demonstrating that
patients with cancer diagnosed in this way have
poorer outcomes.
▪ While we carried out a comprehensive review of
the world literature, few evaluative studies were
identified, with most researchers undertaking
observational work utilising routine data.
▪ Variations in study design, populations under
study and the healthcare settings involved pre-
cluded pooling data for meta-analysis.
Nevertheless, while the majority of studies were
descriptive in nature, they were for the most part
of good quality.
▪ Despite the lack of controlled studies, we have
been able to carry out a definitive synthesis of
existing evidence on this topic, and have identi-
fied some clear messages.
▪ Evidence from the review demonstrates that
patient-related factors, such as age, gender and
socioeconomic deprivation, increase the likeli-
hood of cancer being diagnosed as the result of
an emergency presentation, and that cancer
symptoms and patterns of healthcare utilisation
are also relevant.
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2-week wait (2WW), general practitioner (GP) referral
(not under 2WW), referral from another hospital spe-
cialty and emergency presentation (EP). The 2WW
system (introduced in 2000), whereby patients are
referred urgently for suspected cancer by their GP and
can expect to be seen by a specialist within 2 weeks, is
seen as being the gold standard for cancer diagnosis.4
Conversely, it is well established that for the majority of
cancers, diagnosis within the context of an EP results in
poorer outcomes.5 Between 2006 and 2010, 23% of all
cancers in England were diagnosed via the emergency
route, with even greater proportions of lung (38%) and
colorectal (25%) cancers diagnosed in this way (http://
www.ncin.org.uk/publications/routes_to_diagnosis).
Across all cancer sites, 1 year relative survival was signiﬁ-
cantly lower than for presentations by other routes, and
was considerably lower than for diagnoses made via the
2WW pathway (colorectal: all routes 74%, 2WW 83%,
emergency 49%; lung: all routes 29%, 2WW 42%, emer-
gency 11%).
Despite the undoubted beneﬁts of improving the diag-
nostic pathway for these patients, as yet we know little
about the context surrounding the route to EP. The
majority of published work has focused on outcomes,6 7
and as such, there is a dearth of evidence relating to the
factors that inﬂuence the presentation itself. The
purpose of this review was to identify the patient and
practitioner factors that inﬂuence cancer diagnosis via
EP, using lung and colorectal cancers as exemplars, and
to determine whether any interventions have been
found to impact on EP.
METHODS
Terminology
The term ‘emergency presentation’ in the cancer litera-
ture is used to denote a variety of routes to diagnosis.
For the purposes of this review, EP was deﬁned as a diag-
nosis of cancer that arose during an unscheduled (or emergency
or unplanned) hospital admission, whether that admission
was initiated by the patient seeking management of the
condition through an emergency portal (such as the
emergency department (ED)), by a primary healthcare
practitioner (including out of hours) admitting a patient
to the ED, acute medical or surgical unit for manage-
ment of an illness that is subsequently diagnosed as
cancer during that admission, or by a hospital practi-
tioner admitting a patient directly from an outpatient
clinic.
Identification of studies
A search of the world literature from 1996 to March
2014 was undertaken. This timescale was selected as it
covers the period following the introduction of the
Calman-Hine report (1995), which set out a strategic
framework for creating a network of cancer care in
England and Wales, thereby transforming cancer ser-
vices. We searched MEDLINE, Ovid (1996 to February
week 2 2014), EMBASE, Ovid (1996 to 2014 week 9),
CINAHL, Ebsco (1996 to March 2014), EBM Reviews
(including the Cochrane Database of Systematic
Reviews), Ovid (1996 to January 2014), Science Citation
Index, ISI Web of Science (1996 to March 2014) and
Social Sciences Citation Index, ISI Web of Science (1996
to March 2014). Supplementary searches of Conference
Proceedings Citation Index-Science and Conference
Proceedings Citation Index-Social Science and
Humanities, ISI Web of Science (1996 to March 2014)
were conducted to provide relevant unpublished work.
In addition, the reference lists of included studies were
reviewed for potentially relevant papers. A range of
MeSH headings and keyword searches were used includ-
ing Primary Health Care/, Secondary Care/, “emer-
gency”, “unscheduled”, “admission”, and “present*”.
A sample search is provided in online supplementary
appendix 1.
Criteria for inclusion
Studies were included if the participants were individual
or groups of adult patients or primary care practitioners,
and they considered factors that were associated with
diagnosis of colorectal or lung cancer in the context of
an EP, or they described an intervention designed to
impact on emergency cancer presentation. Studies of
any research design were considered (with the exception
of single case reports), and no language restrictions
were imposed. Studies involving patients who had previ-
ously had a diagnosis of cancer were excluded, as were
those that assessed only the effectiveness of speciﬁc
referral pathways (eg, 2WW). Similarly, studies focusing
only on outcomes related to diagnosis via EP or on man-
agement following EP were also excluded (see online
supplementary appendix 2).
Screening and data extraction
Titles and abstracts of all identiﬁed studies were inde-
pendently screened for eligibility by two reviewers, and
full-text versions of papers not excluded at this stage
obtained for detailed review. Potentially relevant studies
were then independently assessed to determine if they
met the inclusion criteria. Differences of opinion were
discussed until a consensus was reached, with the
opinion of a third reviewer sought where necessary. Data
extraction on a sample of included studies (n=10) was
carried out by two reviewers (BP-S and EDM) using a
standardised proforma, with the remainder completed
by one reviewer (EDM). Data included research design
and location, study setting, participants, emergency
pathway, and results.
Assessment of evidence
Assessment of study evidence was carried out by one
reviewer (EDM). Where possible, studies were evaluated
using previously developed scoring systems (ie, the
Newcastle-Ottawa scale for case–control studies).
However, many of the papers included in this review
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used methodologies that did not lend themselves to the
scoring systems outlined. A method of assessing the
strength of evidence of observational studies—developed
as part of a previous systematic review on early diagnosis
of cancer8 9—was therefore modiﬁed for this topic area,
and applied to relevant studies.
In this system, papers were evaluated on the basis of
‘population’, ‘ascertainment’ and ‘analysis’ (see online
supplementary appendix 3). Population relates to the
method used to ensure an appropriately powered study/
generalisable results, with use of a sample size calcula-
tion or inclusion of all possible patients/providers rated
more highly than selective recruitment. Ascertainment
relates to methods of obtaining study data, with use of a
rigorous method designed to reduce systematic differ-
ences between groups (selection, characteristics, etc)
rated more highly than other methods. Finally, analysis
relates to use of analytic techniques, with reporting of
relevant statistical comparisons/differences (or use of
appropriate analytic techniques if qualitative) rated
more than highly than non-statistical comparisons or
descriptive data. Evidence was assessed as strong if a
paper was graded strong for population, ascertainment
and analysis, strong– if graded as strong for two of the
areas and moderate for one area, and moderate if graded
as strong for one area and moderate for two areas, or as
moderate for all three areas. Evidence was considered to
be insufﬁcient if a paper used a selective study population
and/or an inappropriate method to ascertain data, or if
it did not provide enough information to be able to
determine a grading. Studies of low quality were not
excluded from the review, but were interpreted in light
of this.
Data synthesis
Substantial clinical and methodological heterogeneity
between studies, along with a dearth of controlled com-
parisons, meant that it was not appropriate to pool data
for meta-analysis. Instead, we carried out a narrative syn-
thesis of ﬁndings to identify key concepts and themes
relating to EP that were shared across individual studies.
In addition, the evidence generated by each study has
been assessed on the robustness of its methodology and
analysis, allowing us to weight each study in our compos-
ite assessment of risk factors for EP.
RESULTS
Description of studies
Search results
The search strategy identiﬁed 927 articles of which 49
appeared to meet the inclusion criteria and were subject
to detailed review (ﬁgure 1). Twenty-two papers, involv-
ing more than 687 000 individuals with lung or colorectal
cancer, were included in the ﬁnal analysis (tables 1–3),
including ﬁve studies identiﬁed from the grey literature.
No non-English language studies were included, and no
relevant qualitative work was identiﬁed. Three papers
dealt with lung cancer alone, 16 dealt with colorectal
cancer (1 also involving upper gastrointestinal cancer),
Figure 1 Flow of studies into the review.
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and 3 considered both lung and colorectal cancers
(plus breast cancer in 2 cases). The majority dealt with
factors relevant to patients; only three reported on
practice-related issues. Only one study (before and after
design) evaluated an intervention.
Populations
Two-thirds of the studies were carried out in Europe
(n=14; 64%), most in the UK (n=11). The remainder
were sited in North America (n=5; 23%), Australia
(n=2; 9%) and Malaysia (n=1; 4%). Studies were rela-
tively large in size, involving between 30 and 373 718
participants (mean 31 269; median 689). In total, more
than 200 000 EPs (mean 10 125; median 178) were
included. It was not possible to determine actual
numbers of EPs for two studies, one abstract only inclu-
sion and one paper where a complete breakdown of
numbers was not provided.
In the main, studies with the largest number of parti-
cipants (>1000) analysed data for cases identiﬁed from
routine data sources, collected either at national
(Hospital Episodes Statistics, National Lung Cancer
Audit), regional (state-wide cancer registry, state-wide
discharge data, Managed Clinical Network, health
authority data) or local level (hospital cancer data-
base).10–19 In the remaining studies (n=12), more than
half involved patients admitted to hospital (62%).20–26
Only one study was based in primary care.27 All but one
of the studies considered patient-related factors, but
only four included patients directly as participants;
none included practitioners.
Emergency presentations
In the majority of studies (n=15; 68%), the authors
included a deﬁnition of the term ‘emergency presenta-
tion’. For the most part, EP related to an admission
made at short notice (either as a result of referral from
a GP or other practitioner, or because the patient
attended the ED) or to a diagnosis made in the ED or
inpatient setting.11 15 16 19 23–26 28 In some of the colo-
rectal cancer literature however, the deﬁnition went
beyond admission to include surgery (sometimes within
a given timeframe) and/or a speciﬁc presenting
symptom such as obstruction or perforation.12–
14 20 21 27
Quality assessment
None of the included studies employed a controlled
trial methodology, with most (n=15; 68%) involving sec-
ondary analysis of routine data, with or without comple-
mentary medical records review.10–19 21 27–30 Only six
studies collected data prospectively, four using a com-
bination of administered patient questionnaire and
medical records review.20 22–26 Fourteen papers were
assessed as providing strong evidence (four graded as
strong–), three provided moderate evidence and ﬁve
were insufﬁcient. Four of the insufﬁcient papers were
abstract only inclusions that provided limited
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information,23 29–31 while the ﬁnal paper lacked detail
on identiﬁcation of patients and methods for collecting
data.20
Patient-related risk factors for EP
Demography
Demographic characteristics were the most commonly
evaluated factors related to EP, and were considered in
17 of the 22 included papers (tables 1, 2 and 4).
Older patient age was found to be a signiﬁcant factor
in all but three of the 14 studies evaluating this, and was
associated with EP for both lung and colorectal
cancers.10–13 15 17–19 21 24–26 28 31 While the speciﬁc at-risk
age varied across studies (60 to ≥90 years), those using
multivariate regression analysis found the odds of EP to
be between 1.11 and 11.03 for older patients with lung
cancer, and between 1.19 and 5.85 for older patients with
colorectal cancer. Women were found to be more at risk
of EP for lung cancer,18 19 28 but there was no clear evi-
dence that this was the case for colorectal cancer, with
studies split between those ﬁnding a positive associ-
ation15 17–19 24 and those ﬁnding none.10 12 21 25 26
Higher socioeconomic deprivation increased the likeli-
hood of EP for lung cancer,11 16 18 but the evidence of a
relationship with presentation for colorectal cancer was
less conclusive.10 14 16 18 25 Those studies that did iden-
tify an association found that between 4% and 21%
more patients in the most deprived group presented as
emergencies compared with patients in the most afﬂu-
ent group. While there was little evidence of an associ-
ation between annual household income and EP in
either cancer group,12 19 24 one study found that lower
individual patient income was linked to emergency diag-
nosis of colorectal cancer.17 Two studies from the USA
found that enrolment in the Medicaid insurance
scheme (OR=2.66; 95% CI 1.89 to 3.72), or self-paying
medical fees (OR=2.08; 95% CI 1.30 to 3.33) increased
the likelihood of EP for colorectal cancer.15 19 However,
this was not the case for lung cancer.19 There was also
some evidence that non-white ethnic origin was a risk
factor for EP, although in the case of colorectal cancer
this was inconclusive.10 15 19
Several additional factors were studied in relation to
EP with colorectal cancer. No deﬁnitive relationship
between education level,12 24 residence (either geo-
graphical area or home ownership)21 and social class26
was identiﬁed, but there was evidence to suggest that
being unmarried (and in some cases divorced or
Table 4 Risk factors for emergency cancer presentation (number of studies)
Risk factor Colorectal cancer Lung cancer
Demographic
Age (older) ● ● ● ● ● ● ● ● ● ⊙ ○ ○ ● ● ● ○
Gender (female) ● ● ● ● ● ○ ○ ○ ○ ○ ● ● ●
Deprivation (higher) ● ● ● ○ ○ ● ● ●
Annual income—household, individual (lower) ● ● ○ ○ ○
Ethnicity (non-white origin) ● ○ ○ ● ⊙
Enrolment in health insurance ● ● ○
Marital status (unmarried, divorced, widowed) ● ● ○
Education level (lower) ● ○
Social class (lower) ○
Residence (ownership, location) ○
Childlessness ●
History
Cancer site (colon) ● ● ⊙ ⊙ ○
Symptom type ● ● ● ⊙ ⊙ ●
Symptom type (pain) ● ● ⊙
Symptom type (weight loss) ● ●
Symptom type (obstruction) ● ⊙
Symptom type (change in bowel habit) ● ⊙
Symptom type (bleeding) ○
Help-seeking at initial symptom ● ○
Comorbidity ● ● ○ ○ ● ○
Performance status (poorer) ●
Smoking history ○
BMI (extreme) ●
Primary care utilisation (lower) ● ● ●
Secondary care utilisation (higher) ● ○ ●
Previous screening/investigation ● ○
Family history of cancer ○ ○
● Study reports association with EP (evidence rated as ‘strong’, ‘strong–’ or ‘moderate’); ⊙ study reports association with EP (evidence rated
as ‘insufficient’); ○ study reports no association with EP.
BMI, body mass index; EP, emergency presentation.
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widowed) increased the likelihood of EP.12 21 25
In addition, one study found that the risk of EP was
increased in those with no children (p=0.021), although
this was not statistically signiﬁcant in multivariate
analysis.12
History
In some cases, the type of symptoms that patients experi-
enced had an effect on presenting behaviour (tables 1,
2 and 4). One lung cancer study found that patients
with non-respiratory symptoms were more likely to
present as an emergency than patients with lung-related
symptoms (cough, chest pain or infection, haemoptysis
or dyspnoea), who were more likely to attend their GP
and be referred electively with a chest X-ray already
carried out (39% EP vs 80% elective).28 Similarly, EP for
colorectal cancer was found to be linked to more
serious symptoms, such as pain, obstruction and weight
loss.24 26 27 29 30 There was also some evidence to
suggest that patients with colon cancer were more likely
to present as emergencies than those with rectal
cancer.10 21 26 30 31 Perhaps unsurprisingly then, rectal
bleeding was not found to be associated with EP, possibly
as a result of patients seeking help earlier with what they
might consider to be a more alarming symptom.27 One
study found that the ﬁrst cancer symptom triggered
help-seeking less often in emergency patients (65.8% vs
86.2%; p<0.01),26 while another found that the time
between ﬁrst symptom and ﬁrst presentation was lower
for patients presenting as emergencies (median 11.5 vs
49.5 days; p=0.04).22
There was conﬂicting evidence about the impact of
coexisting morbidity on presenting behaviour. Half of
the studies evaluating this found that it increased the
likelihood of EP, while the other half found that it did
not; this was found to be the case for both lung11 19 and
colorectal cancers.10 17 19 21 However, the method of
identifying (national cancer audit, cancer registry, hos-
pital records) and classifying comorbidity (individual
conditions, Charlson score, Deyo score) varied across
studies, and this may have impacted on the consistency
of ﬁndings. One lung cancer study found that the odds
of EP were higher for patients with worse performance
status (PS4 OR=9.14; 95% CI 8.51 to 9.82),11 while an
additional colorectal study found a signiﬁcant associ-
ation between body mass index (BMI) and EP, with
underweight (BMI <25) and severely obese patients
(BMI >40) having the highest rates of emergency diag-
nosis (32% and 42% of patients, respectively; p=0.001).24
There was no evidence of an association with smoking
history.24
There was evidence that lack of a regular source of
primary care,17 and lower use of primary care (no visits
in the 12 months before diagnosis)19 were positively
associated with EP, the latter for both lung and colorec-
tal cancers. One of the studies also found that lung and
colorectal patients who had at least one hospital admis-
sion in the 12 months before diagnosis were more likely
to present as emergencies. In addition, patients diag-
nosed in the ED had a signiﬁcantly higher average
number of ED visits before cancer diagnosis compared
with patients diagnosed in other settings (lung 0.61 vs
0.33; colorectal 0.58 vs 0.29; p<0.05).19 However, both
studies were undertaken in North America, and given
differences in healthcare provision may not be wholly
generalisable to a UK setting.
Patients who had not had a bowel-related investigation
in the 5 years prior to diagnosis of colorectal cancer
(colonoscopy, ﬂexible sigmoidoscopy, barium enema)
were found in one study to be at increased risk of EP
(OR for investigation 0.69; 95% CI 0.63 to 0.75).17
Conversely, previous colorectal cancer screening did not
appear to have any impact, although the authors of this
Canadian study did remark that there was no organised
screening programme in place at that time, and only
24% of the patient cohort had ever had a screening test
for colorectal cancer.24 There was no evidence that
family history of colorectal cancer had an effect on pres-
entation behaviour.24 26
Practice-related risk factors for EP
Only three studies reported on aspects of practice that
could be considered to be related to EP (table 3).
In one observational before and after study, Davies
et al20 studied the impact of the introduction of a fast-
track ﬂexible sigmoidoscopy referral system. They found
that EPs for colorectal cancer fell from 35.7% in the
year prior to the introduction of the service to 25.9% in
the years following, although the difference did not
reach statistical signiﬁcance (p=0.059). One study from
the UK found that the organisational characteristics of a
patient’s registered practice (number of GPs, fundhold-
ing status, training status) were not signiﬁcant in relation
to whether a patient was diagnosed electively or as an
emergency.25 The study did not consider the character-
istics of individual GPs which may have been more likely
to impact on referral behaviours. The ﬁnal study did not
consider practice aspects per se, but rather inferred that
the inclusion of certain components in the referral
pathway would reduce EP, namely that patients with lung
cancer should have a chest X-ray carried out.22 However,
most emergency patients in the study did not present
with respiratory symptoms, and as such, the indications
for chest X-ray would undoubtedly be limited.
DISCUSSION
Principal findings
Our review has for the ﬁrst time synthesised available
evidence on factors associated with diagnosis of colorec-
tal or lung cancer during an EP. As such, it is a valuable
addition to previous work that demonstrates that
patients diagnosed with cancer in the context of an EP
have poorer outcomes.5 In undertaking this review, we
have also demonstrated that in general this topic is
under-researched, yet despite the relative lack of
10 Mitchell ED, et al. BMJ Open 2015;5:e006965. doi:10.1136/bmjopen-2014-006965
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evidence, the review has established a number of associa-
tions. We have identiﬁed older age in both colorectal
and lung cancers as a risk factor for EP, and have shown
a link between EP for lung cancer with women and
more deprived groups. There is also some evidence that
these factors may increase the likelihood of EP for colo-
rectal cancer, although this is not conclusive. Other
demographic factors which may be a proxy for living
alone (unmarried, divorced, widowed) also appear to
have an association with emergency diagnosis of colorec-
tal cancer.
Unsurprisingly, symptoms associated with bowel
obstruction (such as pain) were more likely to result in
an EP for colorectal cancer, but interestingly, so too were
some symptoms that are likely to have been present for
longer, such as weight loss. Patients with lung cancer
who did not have commonly associated respiratory symp-
toms that might lead to a chest X-ray (cough, chest pain,
or infection) or a red ﬂag symptom, such as haemopty-
sis, also had increased odds of presenting as an
emergency.
Although fewer studies reported on more process-
based issues, lower primary care and higher secondary
care utilisation were perhaps unsurprisingly associated
with diagnosis during EP. However, it was not possible to
determine the reasons associated with these utilisation
patterns, and as such, we are limited in what we can
learn from them.
Strengths and limitations
While we carried out a comprehensive review of the
world literature, few evaluative studies were identiﬁed,
with most researchers undertaking observational work
utilising routine data. No randomised controlled trials
were identiﬁed (perhaps as expected given the area of
study), and variations in study design, populations under
study and the healthcare settings involved precluded
pooling data for meta-analysis. Nevertheless, while the
majority of studies were descriptive in nature, they were
for the most part of good quality. Only ﬁve studies were
rated as insufﬁcient, four of which were identiﬁed from
the grey literature and were limited by the completeness
of their reporting. Despite the lack of controlled studies,
we have been able to carry out a deﬁnitive synthesis of
existing evidence on this topic, and have identiﬁed some
clear messages.
Implications for clinicians, policy and research
There is a paucity of research into the factors associated
with reasons for diagnosis of cancer during an EP. We
were able to identify only 22 studies considering possible
risk factors, and with the exception of studies reporting
age and gender, we were unable to ﬁnd more than ﬁve,
often less, evaluating any of the other demographic or
patient-related factors identiﬁed. Additionally, there is a
dearth of evidence related to the potential impact of
primary care practice and practitioner-related factors on
EP, and limited research designed to identify and evalu-
ate possible interventions.
While this review has shed some light on some of the
factors that are associated with this, we are still unable to
determine what happens to patients before they present,
and indeed, whether this links to previous work on
patient and practitioner delay.8 9 It is often hypothesised
that patients who present as emergencies have had some
delay on the pathway to diagnosis, but as yet we are
unable to conclude that this is the case. A case–control
study funded by the National Awareness and Early
Diagnosis Initiative (NAEDI) and starting in 2014 is
designed to provide some of this evidence.32 It is vital
that we understand this pre-presentation phase if we are
to develop interventions to impact on the poor out-
comes associated with diagnosis during EP. While it may
be the case that not all patients with lung and colorectal
cancers (especially lung cancer) would beneﬁt from
earlier diagnosis in terms of mortality, ensuring that
delays in the pathway to diagnosis are minimised would
at the very least be transformative to patient experience.
In addition, work is needed to develop an understand-
ing of why older people and women appear more likely
to have cancers diagnosed in this way.
CONCLUSIONS
Evidence from this review has demonstrated that certain
patient-related factors, such as age, gender and socio-
economic deprivation, have an inﬂuence on diagnosis of
cancer during an EP. It also shows that cancer symptoms
and patterns of healthcare utilisation are relevant. While
it may be the case that such patients become sick very
quickly and need to be admitted to hospital, further
work is needed to understand the context in which risk
factors for EP exist and inﬂuence help-seeking behav-
iour. Until then, we may be unable to develop suitable
interventions to ensure that patients are detected earlier
in their pathway to diagnosis.
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